PHA-793887
Star0
This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Generic Name
- PHA-793887
- DrugBank Accession Number
- DB12686
- Background
PHA-793887 has been used in trials studying the treatment of Advanced/Metastatic Solid Tumors.
- Type
- Small Molecule
- Groups
- Investigational
- Structure
- Weight
- Average: 361.4817
Monoisotopic: 361.247775261 - Chemical Formula
- C19H31N5O2
- Synonyms
- Not Available
- External IDs
- PHA-793887
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Categories
- Drug Categories
- Chemical TaxonomyProvided by Classyfire
- Description
- This compound belongs to the class of organic compounds known as piperidinecarboxamides. These are compounds containing a piperidine ring substituted with a carboxamide functional group.
- Kingdom
- Organic compounds
- Super Class
- Organoheterocyclic compounds
- Class
- Piperidines
- Sub Class
- Piperidinecarboxylic acids and derivatives
- Direct Parent
- Piperidinecarboxamides
- Alternative Parents
- N-arylamides / Pyrrolopyrazoles / Fatty amides / Imidolactams / Heteroaromatic compounds / Tertiary carboxylic acid amides / Pyrazoles / Pyrroles / Secondary carboxylic acid amides / Amino acids and derivatives show 6 more
- Substituents
- Amine / Amino acid or derivatives / Aromatic heteropolycyclic compound / Azacycle / Azole / Carbonyl group / Carboxamide group / Carboxylic acid derivative / Fatty acyl / Fatty amide show 18 more
- Molecular Framework
- Aromatic heteropolycyclic compounds
- External Descriptors
- Not Available
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- MKS45S912B
- CAS number
- 718630-59-2
- InChI Key
- HUXYBQXJVXOMKX-UHFFFAOYSA-N
- InChI
- InChI=1S/C19H31N5O2/c1-12(2)10-15(25)20-17-14-11-24(19(3,4)16(14)21-22-17)18(26)13-6-8-23(5)9-7-13/h12-13H,6-11H2,1-5H3,(H2,20,21,22,25)
- IUPAC Name
- N-[6,6-dimethyl-5-(1-methylpiperidine-4-carbonyl)-1H,4H,5H,6H-pyrrolo[3,4-c]pyrazol-3-yl]-3-methylbutanamide
- SMILES
- CC(C)CC(=O)NC1=NNC2=C1CN(C(=O)C1CCN(C)CC1)C2(C)C
References
- General References
- Not Available
- External Links
- PubChem Compound
- 46191454
- PubChem Substance
- 347828888
- ChemSpider
- 24747380
- BindingDB
- 50378657
- ChEBI
- 91371
- ChEMBL
- CHEMBL1230607
- ZINC
- ZINC000052509437
- PDBe Ligand
- 889
- PDB Entries
- 2wpa
Clinical Trials
- Clinical Trials
Phase Status Purpose Conditions Count 1 Terminated Treatment Advanced or Metastatic Solid Tumor 1
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source Water Solubility 0.0937 mg/mL ALOGPS logP 2.01 ALOGPS logP 1.57 Chemaxon logS -3.6 ALOGPS pKa (Strongest Acidic) 11.15 Chemaxon pKa (Strongest Basic) 8.79 Chemaxon Physiological Charge 1 Chemaxon Hydrogen Acceptor Count 4 Chemaxon Hydrogen Donor Count 2 Chemaxon Polar Surface Area 81.33 Å2 Chemaxon Rotatable Bond Count 4 Chemaxon Refractivity 104.73 m3·mol-1 Chemaxon Polarizability 41.3 Å3 Chemaxon Number of Rings 3 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter Yes Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
Spectrum Spectrum Type Splash Key Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS splash10-03di-0009000000-6e60a8ae0e64e248afff Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS splash10-03di-0019000000-3f1e6ac54172dd06fce4 Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS splash10-03di-1149000000-47bbd4c763ad34cc35fe Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS splash10-024i-4095000000-ff82046839d2a2210d54 Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS splash10-0udi-4906000000-57127a3ddc4c04eeee24 Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS splash10-01r7-6976000000-674c11bf01452d7216ae Predicted 1H NMR Spectrum 1D NMR Not Applicable Predicted 13C NMR Spectrum 1D NMR Not Applicable - Chromatographic Properties
Collision Cross Sections (CCS)
Adduct CCS Value (Å2) Source type Source [M-H]- 210.514429 predictedDarkChem Lite v0.1.0 [M-H]- 193.52097 predictedDeepCCS 1.0 (2019) [M+H]+ 211.442229 predictedDarkChem Lite v0.1.0 [M+H]+ 195.87895 predictedDeepCCS 1.0 (2019) [M+Na]+ 210.626029 predictedDarkChem Lite v0.1.0 [M+Na]+ 202.50941 predictedDeepCCS 1.0 (2019)
Drug created at October 20, 2016 23:37 / Updated at June 12, 2020 16:53